Elevation Oncology Inc. Gains 106.95%
Mon, Jan 08, 2024 at 07:36 PM
Elevation Oncology Inc. (ELEV:NASDAQ) jumped higher at $1.81, a gain of 107%. On Mon, Jan 08, 2024, ELEV:NASDAQ hit a New 2-Week High of $1.81. From Tue, Dec 26, 2023, the stock recorded 50.00% Up Days and 66.67% Green Days
About Elevation Oncology Inc. (ELEV:NASDAQ)
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 59900%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 141.94%
- Harpoon Therapeutics, Inc. (HARP:NASDAQ), 111.94%
- Elevation Oncology Inc. (ELEV:NASDAQ), 106.95%
- Ambrx Biopharma Inc. (AMAM:NASDAQ), 101.54%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 101.54%
- Nkarta Inc. (NKTX:NASDAQ), 77.06%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 63.64%
- Universe Pharmaceuticals Inc (UPC:NASDAQ), 46.15%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 45.83%